Literature DB >> 25347944

Clinical trials: cardiovascular benefits of paricalcitol in chronic kidney disease.

Jessica K Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25347944     DOI： 10.1038/nrneph.2014.200

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Paricalcitol and endothelial function in chronic kidney disease trial.

Authors:  Carmine Zoccali; Giuseppe Curatola; Vincenzo Panuccio; Rocco Tripepi; Patrizia Pizzini; Marica Versace; Davide Bolignano; Sebastiano Cutrupi; Raffaele Politi; Giovanni Tripepi; Lorenzo Ghiadoni; Ravi Thadhani; Francesca Mallamaci
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190
  1 in total
  1 in total

1.  B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway.

Authors:  Jiemei Li; Jing Niu; Wenjian Min; Jun Ai; Xu Lin; Jinhua Miao; Shan Zhou; Ye Liang; Shuangqin Chen; Qian Ren; Kunyu Shen; Qinyu Wu; Xiaolong Li; Weiwei Shen; Fan Fan Hou; Youhua Liu; Peng Yang; Lili Zhou
Journal:  Cell Death Differ       Date:  2022-06-16       Impact factor: 15.828
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.